Asymmetric synthesis with cinchona-decorated CD in a continuous-flow membrane reactor
Over the last two decades organocatalysis has become an attractive synthetic tool in asymmetric catalysis. However, the increasing demand for
Category: CD derivatives
NO-delivering fluorescent beta-cyclodextrin polymer
A novel water-soluble β-cyclodextrin branched polymer covalently integrating a fluorescein moiety and a nitric oxide (NO) photodonor within its macromolecular
Carbohydrate drugs (Part 5) (Oligosaccharides, cyclodextrins)
First let’s talk about one of the biggest achievements in the history of cyclodextrin research: Sugammadex. Sugammadex (SGM) (BridionTM) (1a)
Lactosyl-β-cyclodextrin against Hepatomegaly in Niemann-Pick Type C Disease
The first paper in the special issue of Nanomaterials “Nanoconstructs Based on Cyclodextrins” has been published. Mono-lactosyl β-CD (mono-Lac-β-CD) diminished
Special issue: Nanoconstructs Based on Cyclodextrins
A special issue in Nanomaterials, an open access journal of MDPI will focus on native or modified CDs leading to
New book: Nanosponges: Synthesis and Applications
Wiley has recently published a book on nanosponges edited by Francesco Trotta and Andrea Mele. The book gives an excellent
Cyclodextrins without holes are reality
The smallest possible cyclodextrins were synthesized by Japanese scientists. They are the first new small cyclodextrins since 1994 when the synthesis of the five membered cyclodextrin was described.
Effect of CD on the antiaging drug: rapamycin
Rapamycin (also known as sirolimus) is a macrolide compound produced by the bacterium Streptomyces hygroscopicus. It is immunosuppressant used to
Cyclodextrins at HPLC 2019 Milan
HPLC 2019, the most important international conference in the field of high-performance liquid phase separations and related techniques, will be
CTD Holdings Announces Plan to Launch Clinical Trial of Trappsol (R) Cyclo (TM) in Alzheimer’s Disease
CTD Holdings, Inc., a clinical stage biotechnology company that develops cyclodextrin-based products for the treatment of disease with unmet medical